Annual sales were KRW 72.3 billion in 2022, KRW 73.7 billion in 2023 (up 2.0%), KRW 71.7 billion in 2024 (down 2.7%) and KRW 81.1 billion in 2025 (up 13.1%). The largest year among 2022 to 2025 was 2025 and the smallest was 2024.
Operating profit fell from KRW 7.22 billion in 2022 to KRW 6.17 billion in 2023 (down 14.6%) and KRW 4.23 billion in 2024 (down 31.5%), then recovered to KRW 5.53 billion in 2025 (up 30.9%).
The operating margin was 10.0% in 2022, 8.4% in 2023, 5.9% in 2024 and 6.8% in 2025, so the margin remained below 2022 even as sales grew in 2025. The company attributed the increase in sales and operating profit in 2025 to recovering demand for scientific instruments.
Profit attributable to controlling shareholders was KRW 4.7 billion in 2022, KRW 3.85 billion in 2023 (down 18.2%), KRW 2.69 billion in 2024 (down 30.0%) and KRW 3.28 billion in 2025 (up 21.9%), with 2022 the largest year.
Net profit including non-controlling interests was KRW 4.78 billion in 2025, a different figure from profit attributable to controlling shareholders.
In quarterly terms, sales were KRW 21.2 billion and operating profit KRW 2.31 billion in Q3 2025, then sales rose to KRW 25.2 billion in Q4 2025 while operating profit fell to KRW 601 million (down 74.0% from the prior quarter).
Profit attributable to controlling shareholders in Q4 2025 was KRW 44.49 million, a low point. Operating profit then rose for three straight quarters, to KRW 973 million in Q1 2026, KRW 2.07 billion in Q2 and KRW 2.32 billion in Q3. Q3 2026 sales were KRW 21.5 billion, down 0.8% from the prior quarter and up 1.2% from a year earlier.